$609.29
2.400.40%
At close: -
$608.90
-0.39-0.06%
After Hours: 6:47 AM EDT
Comments
Loading...
Chemed Stock Guidance | NYSE:CHE | Benzinga
Chemed issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/26/2025 | CHE | Chemed | FY | 2025 | $24.95 | $25.45 | $24.89 | — | — | — | Get Alert |
| 10/29/2024 | CHE | Chemed | FY | 2024 | $23.00 | $23.15 | $23.58 | — | — | — | Get Alert |
| 07/24/2024 | CHE | Chemed | FY | 2024 | $23.55 | $23.80 | $23.21 | — | — | — | Get Alert |
| 04/24/2024 | CHE | Chemed | FY | 2024 | $23.30 | $23.70 | $23.52 | — | — | — | Get Alert |
| 02/27/2024 | CHE | Chemed | FY | 2024 | $23.30 | $23.70 | $23.01 | — | — | — | Get Alert |
| 10/25/2023 | CHE | Chemed | FY | 2023 | $19.82 | $20.02 | $19.98 | — | — | — | Get Alert |
| 07/26/2023 | CHE | Chemed | FY | 2023 | $19.90 | $20.10 | $20.92 | — | — | — | Get Alert |
| 02/23/2023 | CHE | Chemed | FY | 2023 | $20.75 | $21.10 | $20.21 | $2.24B | $2.25B | $2.21B | Get Alert |
| 10/31/2022 | CHE | Chemed | FY | 2022 | $19.60 | $19.70 | $19.49 | — | — | — | Get Alert |
| 07/27/2022 | CHE | Chemed | FY | 2022 | $19.30 | $19.50 | $19.47 | — | — | — | Get Alert |
| 02/24/2022 | CHE | Chemed | FY | 2022 | $19.10 | $19.50 | $19.31 | — | — | — | Get Alert |
| 10/28/2021 | CHE | Chemed | FY | 2021 | $19.00 | $19.20 | $17.91 | — | — | — | Get Alert |
| 07/27/2021 | CHE | Chemed | FY | 2021 | $18.20 | $18.50 | $17.35 | — | — | — | Get Alert |
| 02/23/2021 | CHE | Chemed | FY | 2021 | $17.00 | $17.50 | $17.28 | — | — | — | Get Alert |
| 10/29/2020 | CHE | Chemed | FY | 2020 | $18.00 | $18.15 | $16.35 | — | — | — | Get Alert |
| 07/29/2020 | CHE | Chemed | FY | 2020 | $16.20 | $16.40 | $16.13 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for Chemed (CHE)?
The most recent guidance for Chemed (CHE) was reported on February 26, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $24.95 to $25.45, compared to the estimated EPS of $24.89. Additionally, Chemed forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.